BSPED2021 Oral Communications Oral Communications 5 (5 abstracts)
An investigation of androgen-responsive non-coding RNAs in boys with atypical genitalia without genetic variants in the androgen receptor (AR)
Malika Alimussina 1 , Martin McMillan 1 , Sandra Chudleigh 2 , Jane D McNeilly 3 , Louise A Diver 2 , Ruth McGowan 1,2 , Edward S Tobias 2,4 & S Faisal Ahmed 1
1Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children, Glasgow, United Kingdom; 2West of Scotland Centre for Genomic Medicine, Queen Elizabeth University Hospital, Glasgow, United Kingdom; 3Biochemistry Department, Queen Elizabeth University Hospital, Glasgow, United Kingdom; 4Academic Medical Genetics and Clinical Pathology, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, United Kingdom
Introduction: Transcriptome analysis of peripheral blood mononuclear cells (PBMC) RNA has identified a set of androgen-responsive non-coding RNAs.
Aim: To quantify the androgen-responsive gene expression and investigate its relationship to the testosterone (T) rise following hCG stimulation in boys with no genetic evidence of androgen insensitivity.
Methods: Boys with suspected DSD who were evaluated at the Royal Hospital for Children, Glasgow from 2018 to 2021 were included. Information on clinical, biochemical and genetic assessment was obtained from clinical records. PBMC RNA was collected before and after hCG stimulation of the testes on day 4 (D4) and day 22 (D22) and gene expression was quantified using QuantStudioTM 3D Digital PCR.
Results: Ten XY boys with atypical genitalia, a median age of 0.8 yrs (0.5,3.4) and no detected AR gene variants were included. The median baseline and peak T was 0.5 nmol/l (0.5,6.8) and 21.7 nmol/l (1.2,42.1), respectively. Within this group, there was one patient who did not show a T response to hCG at all on D4 and a minimal response on D22 (1.2 nmol/l). The median fold change in SNORD5 and RNY5 on D4 in this patient was 0.09 and 0.05, respectively. The median fold change for the two genes on D22 was 0.14 and 0.04, respectively. In the rest of the cohort, the median post-hCG T on D4 and D22 was 16 nmol/l (2.5,42) and 25 nmol/l (17,37), respectively. In this group, the median fold change in SNORD5 expression on D4 and D22 was 4.0 (0.25,14) and 1.2 (0.1,5.6), respectively. The median fold change in RNY5 expression on D4 and D22 was 1.0 (0.1,38) and 0.5 (0.2,7.7), respectively.
Conclusions: Expression levels of RNY5 and SNORD5 can be quantified accurately and show androgen dependency. Further research in genetically confirmed cases of androgen insensitivity plus those with no response to hCG stimulation is required to determine the diagnostic role of non-coding RNAs in XY DSD.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more